A new RNA-based therapy aims to address one of cardiology’s most persistent challenges: the heart’s inability to regenerate after injury.

‘If the vial is not prepared correctly and it’s not sterile, there’s a real risk of infection’ warns Dr McGuire, and without ...

In the battle of the obesity bulge, glucagon-like peptide-1 receptor agonist medications — aka GLP-1s such as Wegovy and Zepbound — have changed the game for some people who've struggled to ...

The U.S. Food and Drug Administration (FDA) is considering whether to allow new ingredients in dietary supplements. The move ...

Peptides like insulin and the now-ubiquitous GLP-1 drugs have become some of the most influential molecules in modern ...

A team at Oregon State University has engineered lipid nanoparticles that deliver messenger RNA to lung tumors while ...

On-body injector delivery of subcutaneous teprotumumab achieves clinically meaningful proptosis reduction in phase 3 thyroid eye disease study.

A doctor weighs in on Luka Doncic’s recovery, explaining how his return timeline could be shortened with specialized injections.

Peptides are being billed as the next big breakthrough in wellness, with more people turning to them for weight loss and anti ...

Interventional pain specialists warn spring activity aggravates back conditions and share how innovative regenerative ...